Multilevel CerviKit includes a complete suite of implants and single-use instruments for anterior cervical spine procedures and expands the company’s single-use cervical spine technology and ASC surgical device portfolio


Xenco Medical launches its Multilevel CerviKit. (Credit: Business Wire)

US-based medical technology company Xenco Medical has announced the US Food and Drug Administration (FDA) approval and commercial launch of its Multilevel CerviKit.

The Multilevel CerviKit includes a complete suite of implants and single-use instruments for 2, 3, and 4 level anterior cervical spine procedures.

Optimised for ambulatory surgery centre setting, the device will expand its advanced single-use cervical spine technology and ASC surgical device portfolio, said the company.

Xenco Medical developed Multilevel CerviKit based on its existing portfolio of disposable spinal implant and instrument platforms included in its ASC CerviKit.

Its cervical plating options will feature an optimally thin profile, an intuitive locking mechanism, and a dual-textured surface for thorough fixation.

The surgical platform is a sterile-packaged, single-use system designed to enhance intraoperative efficiency, said Xenco.

Xenco Medical founder and CEO Jason Haider said: “As Covid-19 spurred increased demand for sterile-packaged, single-use spinal platforms, we have bolstered our commitment to expanding access to safer, streamlined surgical procedures through the launch of our single-use Multilevel CerviKit.”

Multilevel CerviKit was developed by combining materials science and mechanical engineering, where a disposable delivery instrument is coupled with single-use surgical instruments.

It features highly reinforced, composite polymer instruments with multilevel anterior cervical plates that allow for both consistent mechanical performance and eliminate expensive logistics related to the autoclave process, said the company.

Multilevel CerviKit is said to strengthen the capability of ambulatory surgery centres to overcome sterilisation limitations while providing optimal care.

Xenco Medical said that its spinal systems have been designed for both surgical performance and logistical efficiency, and to be easily transportable.

Its disposable spinal implant systems are optimally calibrated and sterile-packaged for individual use.

Furthermore, the single-use spinal implant systems are designed to be compatible with the company’s intelligent surgical vending machines and can be trained using its glasses-free holographic surgical simulation platform.